Sustained activation and tumor targeting of NKT cells using a CD1d-anti-HER2-scFv fusion protein induce antitumor effects in mice.
Stirnemann, Kathrin 1; Romero, Jackeline F. 1; Baldi, Lucia 2; Robert, Bruno 3; Cesson, Valerie 1,4; Besra, Gurdyal S. 5; Zauderer, Maurice 6; Wurm, Florian 2; Corradin, Giampietro 1; Mach, Jean-Pierre 1; MacDonald, H. Robson 4; Donda, Alena 1
[Article] Journal of Clinical Investigation. 118(3):994-1005, March 2008.

(Format: HTML, PDF)